FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

945481000168102: Ondansetron (Mylan) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3061921000168117 Ondansetron (Mylan) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3061931000168119 Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule has manufactured dose form injection true Inferred relationship Some
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Is a ondansetron 4 mg/2 mL injection, ampoule true Inferred relationship Some
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Is a trade product unit of use true Inferred relationship Some
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Is a Ondansetron (Mylan) true Inferred relationship Some
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule has manufactured dose form injection solution false Inferred relationship Some
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule has unit of use ampoule true Inferred relationship Some 962453499
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule has Australian BoSS ondansetron true Inferred relationship Some 962453498
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule has intended active ingredient ondansetron true Inferred relationship Some 962453498
Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule has TPUU True Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Inferred relationship Some 1
Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule has TPUU True Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Inferred relationship Some 1
Ondansetron (Mylan) (ondansetron 4 mg / 2 mL) injection, 5 x 2 mL ampoules (containered trade product pack) has TPUU True Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Inferred relationship Some 1
Ondansetron (Mylan) 4 mg/2 mL injection, 5 x 2 mL ampoules has TPUU True Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Inferred relationship Some 1
Ondansetron (Mylan) 4 mg/2 mL injection, 10 x 2 mL ampoules has TPUU True Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Inferred relationship Some 1
Ondansetron (Mylan) 4 mg/2 mL injection, 10 x 2 mL ampoules has TPUU True Ondansetron (Mylan) 4 mg/2 mL injection, 2 mL ampoule Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start